| abstract |
The invention provides antibodies directed against ICOS (inducible T-cell co-stimulator) and the use of these antibodies for the treatment of a disease selected from an autoimmune disease, a transplant rejection reaction or a graft versus host disease, as well as an inflammatory disorder. |